cows' milk protein allergy and enteropathy
Metabolic · 2017–2024
Every decision
| Medicine | Meeting | Outcome | Consumer input |
|---|---|---|---|
| amino acid formula supplemented with prebiotics, probiotics and long chain polyunsaturated fatty acids Treatment of cows' milk protein enteropathy, severe cows' milk protein enteropathy with failure to thrive, combined intolerance to cows' milk protein, soy… | Mar 2024 | Recommended | input received Australasian Society of Clinical Immunology and Allergy · National Allergy Council · Anaphylaxis Australia |
| amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids Cows' milk anaphylaxis, severe cows' milk protein enteropathy with failure to thrive, combined intolerance to cows' milk protein, soy protein and protein… | Mar 2023 | Recommended | none received |
| amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids, medium chain triglycerides, 2'-fucosyllactose and lacto-N-neotetraose Treatment of cows' milk protein enteropathy, severe cows' milk protein enteropathy with failure to thrive, combined intolerance to cows' milk protein, soy… | Nov 2022 | Recommended with restriction | input received |
| amino acid formula supplemented with prebiotics, probiotics and long chain polyunsaturated fatty acids Dietary management of cow's milk allergy, multiple protein food intolerance, eosinophilic oesophagitis, and severe intestinal malabsorption including short… | Jul 2017 | Recommended with restriction | none received |
Who spoke
Australasian Society of Clinical Immunology and Allergy · National Allergy Council · Anaphylaxis Australia
What the PBS pays
$18M in government benefit over 2024–25, across 66,196 services.
This is spend on the medicines considered for this condition, not spend on the disease. A medicine used for several conditions is counted in full under each, so figures across conditions add to more than national PBS expenditure.
| Medicine | Government benefit |
|---|---|
| amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids, medium chain triglycerides, 2'-fucosyllactose and lacto-N-neotetraose | $9.1M |
| amino acid formula supplemented with prebiotics, probiotics and long chain polyunsaturated fatty acids | $4.5M |
| amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids | $4.5M |
Conditions are classified by a language model from the indication text of each submission, so an individual label here can be wrong. Consumer input is read from the document's own consumer comments section: 2 of 4 decisions since 2014 carried some. Silence means no comment reached the committee through that facility, not that nobody was affected. More on how this was built.